BioCentury | Aug 14, 2020
Finance

OSI leverages foundational deal with Oxford to build its life sciences portfolio

...to universities may not have the same level of access or financial firepower. For example, Cambridge Innovation Capital...
BioCentury | Nov 1, 2019
Financial News

Nov. 1 Financial Quick Takes: Kira raises $13.8M series A; plus SinoMab, Tot, Shasqi and Sense Biodetection

...Sense Biodetection Ltd. raised £10.5 million ($13.6 million) in a series A round co-led by Cambridge Innovation Capital...
BioCentury | Sep 3, 2019
Financial News

Gyroscope nets £50.4M to advance dry AMD gene therapy

...entirely from majority shareholder Syncona Ltd., which invested £48 million in the deal. Existing investor Cambridge Innovation Capital...
BioCentury | Jul 30, 2019
Financial News

June 30 Financial Quick Takes: $40M series B for Hinova; plus TriArm and PredictImmune raise rounds

...U.K.) completed a £10 million ($12.3 million) series B round, with new investors BGF and Cambridge Innovation Capital...
BioCentury | May 20, 2019
Financial News

May 20 Financial Quick Takes: Schrödinger tops off E round; plus Mabpharm IPO update, DNA Script, ADMA Biologics, Storm

...$38.3 million), to advance its preclinical pipeline. New investor Seroba Life Sciences joined existing investors Cambridge Innovation Capital...
BioCentury | Apr 30, 2019
Financial News

April 30 Financial Quick Takes: Mustang, Tot Biopharm, Axcella and more

...out of the University of Cambridge with £3.4 million ($4.4 million) in seed funding from Cambridge Innovation Capital...
BioCentury | Apr 26, 2019
Financial News

Schizophrenia therapy developer Karuna among four biotechs to file for IPOs

...stake in Bicycle are Vertex Healthcare, Novartis BioVentures, Tybourne Capital, SR One, SV Life Sciences, Cambridge Innovation Capital...
BioCentury | Apr 23, 2019
Finance

Accelerating innovations in Cambridge

...As the Cambridge, U.K., life sciences start-up environment continues to flourish, Cambridge Innovation Capital’s Michael Anstey believes the...
...that guides molecule design, patient stratification or target identification -- areas of particular interest to Cambridge Innovation Capital...
...have a VC, a major pharma, a world-renowned angel and a research campus.” Anstey said Cambridge Innovation Capital’s...
BioCentury | Apr 1, 2019
Finance

Backing Cambridge's AI boom

...After raising £150 million ($196 million) in its latest fund, Cambridge Innovation Capital will be keeping an eye...
BioCentury | Apr 1, 2019
Financial News

Cambridge Innovation raises £150M

...of 25 companies and invest in spinouts from the University of Cambridge and Cambridge area. Cambridge Innovation Capital...
Items per page:
1 - 10 of 42
BioCentury | Aug 14, 2020
Finance

OSI leverages foundational deal with Oxford to build its life sciences portfolio

...to universities may not have the same level of access or financial firepower. For example, Cambridge Innovation Capital...
BioCentury | Nov 1, 2019
Financial News

Nov. 1 Financial Quick Takes: Kira raises $13.8M series A; plus SinoMab, Tot, Shasqi and Sense Biodetection

...Sense Biodetection Ltd. raised £10.5 million ($13.6 million) in a series A round co-led by Cambridge Innovation Capital...
BioCentury | Sep 3, 2019
Financial News

Gyroscope nets £50.4M to advance dry AMD gene therapy

...entirely from majority shareholder Syncona Ltd., which invested £48 million in the deal. Existing investor Cambridge Innovation Capital...
BioCentury | Jul 30, 2019
Financial News

June 30 Financial Quick Takes: $40M series B for Hinova; plus TriArm and PredictImmune raise rounds

...U.K.) completed a £10 million ($12.3 million) series B round, with new investors BGF and Cambridge Innovation Capital...
BioCentury | May 20, 2019
Financial News

May 20 Financial Quick Takes: Schrödinger tops off E round; plus Mabpharm IPO update, DNA Script, ADMA Biologics, Storm

...$38.3 million), to advance its preclinical pipeline. New investor Seroba Life Sciences joined existing investors Cambridge Innovation Capital...
BioCentury | Apr 30, 2019
Financial News

April 30 Financial Quick Takes: Mustang, Tot Biopharm, Axcella and more

...out of the University of Cambridge with £3.4 million ($4.4 million) in seed funding from Cambridge Innovation Capital...
BioCentury | Apr 26, 2019
Financial News

Schizophrenia therapy developer Karuna among four biotechs to file for IPOs

...stake in Bicycle are Vertex Healthcare, Novartis BioVentures, Tybourne Capital, SR One, SV Life Sciences, Cambridge Innovation Capital...
BioCentury | Apr 23, 2019
Finance

Accelerating innovations in Cambridge

...As the Cambridge, U.K., life sciences start-up environment continues to flourish, Cambridge Innovation Capital’s Michael Anstey believes the...
...that guides molecule design, patient stratification or target identification -- areas of particular interest to Cambridge Innovation Capital...
...have a VC, a major pharma, a world-renowned angel and a research campus.” Anstey said Cambridge Innovation Capital’s...
BioCentury | Apr 1, 2019
Finance

Backing Cambridge's AI boom

...After raising £150 million ($196 million) in its latest fund, Cambridge Innovation Capital will be keeping an eye...
BioCentury | Apr 1, 2019
Financial News

Cambridge Innovation raises £150M

...of 25 companies and invest in spinouts from the University of Cambridge and Cambridge area. Cambridge Innovation Capital...
Items per page:
1 - 10 of 42